Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease
Sponsor: The University of Hong Kong
Summary
Non-alcoholic fatty liver disease (NAFLD) affects 25% of the global population and causes serious complications, including cirrhosis, hepatocellular carcinoma or mortality. Unfortunately, there are not yet any approved drugs to treatment NAFLD. The only effective means to improve NAFLD is by weight reduction via lifestyle modifications, i.e., diet and physical activity. Most NAFLD patients lack the motivation to initiate and maintain lifestyle modifications. The investigators hypothesize that ambulatory monitoring of liver fat can help NAFLD patients lose more liver fat by motivating them to gain a sense of control over their condition.
Official title: Effectiveness of Ambulatory Liver Fat Monitoring in Improvement of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: a Multi-center Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2023-05-01
Completion Date
2025-10-31
Last Updated
2024-05-08
Healthy Volunteers
No
Conditions
Interventions
Ambulatory monitoring of liver fat
Participants will be given a novel portable, home-based device called the Gense-EIT liver scan the participants and will practice ambulatory liver fat monitoring for 6 months.
Standard of care
Subjects will have follow-up every 6 months by hepatologists for routine care
Locations (1)
The University of Hong Kong
Hong Kong, Select A State Or Province, China